AUDIO / VIDEO
Episode 133: The HIV Hideoout May 15, 2011
Vincent, Rich, Alan, and Dickson discuss the cellular reservoir of HIV-1 with Kathleen Collins, MD, PhD.
CANADA
Canadian Press May 17, 2011
Doctors are questioning whether the standard early-childhood, two-dose inoculation for measles, mumps and rubella, known as the MMR vaccine, is enough to provide lasting immunity against the virus
Canadian Press May 14 2011
Residents in southern Manitoba and Quebec not only have to worry about water-damaged homes, but diseases, parasites and the psychological stress that can follow flooding, medical experts say.
INTERNATIONAL
Washington Post – 17 May 2011
Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren’t infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine.
South Africa: Ten years of HIV treatment
PlusNews 17 May 2011
Ten years ago, Khayelitsha, in Cape Town, was the first place to make antiretroviral drugs available to the public sector, marking a milestone in the beginning of the end of AIDS denialism and the fight for treatment in South Africa
Bloomberg May 17, 2011
The biotechnology industry is starting to fill a critical public-health niche being mostly shunned by larger drugmakers. Since 2006, only three of 111 drugs cleared in the U.S. were antibiotics.
Kaiser May 17, 2011
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, on Tuesday called for a "Decade of Vaccines" in a keynote address at the World Health Assembly in Geneva, saying strengthening immunization programs against infectious diseases worldwide could save 10 million lives by 2020,
ForeignPolicy blog May 16, 2011
During its short but painful existence in humans, HIV/AIDS has thwarted efforts at prevention. Vaccines have proven elusive; changing human behaviors that spread the disease is never as easy as we'd like. HIV in particular is wrapped in a complicated web of women's rights, sexual mores, and a fraught debate over family planning.
Wall Street Journal May 13, 2011
The Clinton Health Access Initiative, founded by former President Bill Clinton, is spearheading this push, with funding from the Bill and Melinda Gates Foundation and the U.K. government. The Clinton team hired former pharmaceutical-company chemists to work on the project. And a key step in the new recipe for making tenofovir was contributed by a student at Howard University in Washington, D.C.
The Telegraph (UK) May 14, 2011
Drugmaker GlaxoSmithKline (GSK) has agreed to publish the prices it charges UNICEF for vaccines given to the world's poorest children amid pressure for more transparency over the cost of immunisations.
Associated Press of Pakistan May 14 2011
During a visit to one of the most affected areas of Karachi to determine how the two UN agencies could help revitalize efforts to stem cases of this debilitating disease WHO Pakistan Representative, Dr Guido Sabatinelli and UNICEF Pakistan Representative, Dan Rohrmann witnessed ongoing polio eradication drive.
During a visit to one of the most affected areas of Karachi to determine how the two UN agencies could help revitalize efforts to stem cases of this debilitating disease WHO Pakistan Representative, Dr Guido Sabatinelli and UNICEF Pakistan Representative, Dan Rohrmann witnessed ongoing polio eradication drive.
Gates leads $23.4M in funding for HIV/AIDS vaccine
Fierce Vaccines May 12, 2011
"IHV's unique and promising HIV/AIDS vaccine candidate is designed to bind to the virus at the moment of infection, when many of the different strains of HIV found around the world can be neutralized," explained Gallo in an article published by IHV.
Fierce Vaccines May 12, 2011
"IHV's unique and promising HIV/AIDS vaccine candidate is designed to bind to the virus at the moment of infection, when many of the different strains of HIV found around the world can be neutralized," explained Gallo in an article published by IHV.
Scientific American May 12, 2011
Studies show that infants with HIV do not respond well to the measles vaccine even when given a second dose at nine months, as the World Health Organization (WHO) currently recommends.
UN News Service May 12, 2011
The trial found that the risk of transmission from an HIV-positive person to an uninfected sexual partner fell by 96 per cent if the appropriate anti-retroviral treatment was followed.
Haiti: Continuing Cholera Outbreak
The New York Times (editorial) May 10, 2011
A United Nations report on the cholera outbreak that has sickened 300,000 Haitians since last fall, killing nearly 5,000, finds evidence to suggest that the disease may have originated at a United Nations military camp north of the capital, which spilled raw sewage into a tributary of the Artibonite River.
PBS NewsHour May 11, 2011
Ukraine has the highest HIV infection rate in Europe and now there are fears its epidemic could spread to neighboring countries. Special correspondent Kira Kay reports from Ukraine on the health issue.
Reuters May 11, 2011
Dr. Louis Picker of the Oregon National Primate Research Center, whose study appear in the journal Nature, said he thinks it will be possible to have a vaccine ready to test in people within three years.
WORLD HEALTH ASSEMBLY 64th SESSION
Delegates from 193 countries met today in Geneva at the start of the World Health Assembly (WHA), which will address several infectious disease topics, including a report from an independent pandemic review committee, a virus-sharing agreement, and the fate of the world's remaining smallpox virus stocks.
NIH STUDY ON EARLY DRUG THERAPY
National Institutes of Health Media Release May 12, 2011
Related Media:
Kaiser Fondation Friday, May 13, 2011 (Links to numerous media articles)
Results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday.
The Economist (Babbage blog) May 12th 2011
The trial in question, organised by an international body called the HIV Prevention Trials Network, and paid for by America’s National Institutes of Health, asked whether treating an infected individual with drugs that suppress his level of HIV also stops him passing the virus on. It turns out that it does.
San Francisco Chronicle Editorial May 14, 2011
A silver bullet to defeat HIV/AIDS still doesn't exist, but the world is getting closer. An international study released this week found that transmission of the virus can be nearly eliminated if patients are simply given drug therapy as early as possible.
Science Speaks blog May 12, 2011
Study results announced this morning unequivocally link early antiretroviral therapy (ART) for HIV-infected persons with a 96.3% less chance of transmitting the virus to an uninfected partner, as well as a decreased risk of contracting tuberculosis (TB), the number one killer of people living with HIV/AIDS
PlusNews 13 May 2011
A landmark study showing major reductions in HIV transmission among discordant couples due to early treatment may fail to have a significant impact on HIV prevention unl ess governments and donors are willing to turn the science into action, HIV advocates say.
